Yaky Yanay
2020
In 2020, Yaky Yanay earned a total compensation of $350.4K as CEO at Pluristem Therapeutics, a 60% decrease compared to previous year.
Compensation breakdown
| Salary | $320,911 |
|---|---|
| Other | $29,466 |
| Total | $350,377 |
Yanay received $320.9K in salary, accounting for 92% of the total pay in 2020.
Yanay also received $29.5K in other compensation.
Rankings
In 2020, Yaky Yanay's compensation ranked 11,843rd out of 13,090 executives tracked by ExecPay. In other words, Yanay earned more than 9.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,843 out of 13,090 | 10th |
Division Manufacturing | 5,063 out of 5,621 | 10th |
Major group Chemicals And Allied Products | 2,067 out of 2,254 | 8th |
Industry group Drugs | 1,804 out of 1,954 | 8th |
Industry Biological Products, Except Diagnostic Substances | 396 out of 411 | 4th |
Source: SEC filing on April 8, 2021.
Yanay's colleagues
We found two more compensation records of executives who worked with Yaky Yanay at Pluristem Therapeutics in 2020.
News
Pluristem Therapeutics CEO Yaky Yanay's 2023 pay jumps 111% to $2.7M
May 1, 2024
Pluristem Therapeutics CEO Yaky Yanay's 2022 pay falls 86% to $1.3M
February 27, 2023
Pluristem Therapeutics Chairman Zami Aberman's 2020 pay falls 54% to $501K
April 8, 2021
Pluristem Therapeutics Chairman Zami Aberman's 2019 pay jumps 85% to $1.1M
May 20, 2020
Pluristem Therapeutics CEO Zami Aberman's 2018 pay falls 83% to $593K
April 25, 2019